Global Hereditary Cancer Testing Market Report 2024

Hereditary Cancer Testing Global Market Report 2024 – By Test Type( Multi Panel Test, Single-site Genetic Test), By Indication( Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications), By End user( Hospital, Clinics, Diagnostic Centers) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Hereditary Cancer Testing Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Hereditary Cancer Testing Market Definition And Segments

The hereditary cancer testing refers to testing methods for hereditary cancers that can identify specific hereditary cancer diseases and disease-related gene mutations. This testing may decrease the risk of developing particular cancer mutants, allowing for a more comprehensive cancer risk for patients. The primary purpose of this cancer testing is to detect hereditary cancer early and maximize patient health outcomes. This testing procedure assists in identifying cancers for which one has a genetic risk and allows them to receive preventive treatment.

The main types of tests for hereditary cancer are multi panel tests and single-site genetic tests. The multi-panel test refers to a hereditary cancer test that is used to detect many chemicals simultaneously. Panels come in a variety of types, from three-panel tests that look for three substances to five, seven, and 12-panel tests. The choice of conducting the required number of tests is up to the tester’s discretion. Hereditary cancer testing is conducted to detect breast cancer, ovarian cancer, colorectal cancer, and other indications that are used in hospitals, clinics, and diagnostic centers.

The hereditary cancer testing market covered in this report is segmented –

1) By Test Type: Multi Panel Test, Single-site Genetic Test

2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

3) By End user: Hospital, Clinics, Diagnostic Centers

The hereditary cancer testing market size has grown rapidly in recent years. It will grow from $3.97 billion in 2023 to $4.43 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising incidence of hereditary cancers, genetic counseling programs, government initiatives for cancer prevention, improved insurance coverage, understanding of gene-environment interactions, patient advocacy and support groups.

The hereditary cancer testing market size is expected to see rapid growth in the next few years. It will grow to $6.7 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to expansion of targeted therapies, advancements in precision medicine, rise in direct-to-consumer testing, global health initiatives, advancements in bioinformatics. Major trends in the forecast period include advancements in genetic sequencing technologies, telemedicine and remote genetic counseling, precision medicine and personalized treatment, cancer risk assessment models, ethical and legal considerations.

Unraveling Hereditary Cancer With The Rising Demand For Hereditary Cancer Testing

The increasing prevalence of hereditary cancer is expected to drive the hereditary cancer testing market. Mutations in specific genes passed down from parents to children cause hereditary cancer syndromes. Hereditary cancer testing can detect specific, heritable, disease-related gene mutations, allowing for a comprehensive cancer risk assessment for patients. For instance, in June 2022, according to an article published on BioMed Central about hereditary cancer in clinical practice, about 10% of pancreatic cancer cases have a genetic background. Furthermore, in May 2021, a Europe-based software company called SOPHiA Genetics, a data-driven medicine software company, stated in an article that hereditary factors account for approximately 10% of cancer cases, with an estimated 20% of cancer patients having a cancer family history. Therefore, the increasing prevalence of hereditary cancer drives the growth of the hereditary cancer testing market.

Hereditary Cancer Testing's Crucial Role Amidst The Escalating Overall Cancer Burden

An increase in the overall cancer burden is expected to propel the hereditary cancer testing market going forward. Cancer is a group of diseases characterized by the uncontrolled and abnormal growth of cells, which can invade and spread to other tissues and parts of the body. In a healthy organism, cells follow a regulated process of growth, division, and death. Hereditary cancer testing plays a critical role in addressing the overall burden of cancer by identifying individuals with a genetic predisposition to certain cancers. By assessing inherited mutations and familial risk factors, this testing helps identify individuals at higher risk, enabling early intervention, personalized treatment plans, and proactive preventive measures. For instance, in October 2023, the EU Science Hub, a Belgium-based European Commission's Joint Research Centre published an article according to which the new cancer cases rose by 2.3 % in compared to 2020, to reach 2.74 million in 2022. Similarly, cancer deaths went up by 2.4 % in 2022 compared to 2020. Therefore, an increase in the overall cancer burden is driving the hereditary cancer testing market.

Major companies operating in the hereditary cancer testing market report are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.

Myriad Genetics' Cutting-Edge Approach In Hereditary Cancer Testing Technology

Technological innovation is a key trend gaining popularity in the hereditary cancer testing market. Key players in the market are focusing on technological innovations to sustain their market positions. For instance, in March 2022, Myriad Genetics, a US-based genetic testing and precision medicine company, launched genetic testing with a Polygenic Breast Cancer Risk Assessment Score for all ancestries. This MyRisk Hereditary Cancer test with RiskScore offers a personalized breast cancer risk assessment to all women who have never been diagnosed with breast cancer, regardless of ancestry.

Elevating Healthcare Through Strategic Collaborations

Major companies collaborate and get into partnerships to strengthen their position in the hereditary cancer testing market. A business strategic partnership refers to a structured affiliation between two or more commercial enterprises, typically established via one or more business agreements or contracts. For instance, in August 2021, Lightbeam Health Solutions, a US-based healthcare company partnered with Ambry Genetics. The collaboration aims to provide precision genetic testing data within the Lightbeam application to help organizations predict increased risk for common cancers and chronic conditions within patient populations. Ambry Genetics is a US-based hereditary cancer genetic testing company.

Exact Sciences' Strategic Acquisition Of Preventiongenetics For Comprehensive Genetic Testing Portfolio

In January 2022, Exact Sciences, a US-based molecular diagnostics company, acquired PreventionGenetics for approximately $190 million. This acquisition provides Exact Sciences' advanced cancer tests portfolio with PreventionGenetics' comprehensive genetic testing portfolio which is complementary in nature. PreventionGenetics will also provide the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases. PreventionGenetics is a US-based genetic testing And DNA testing laboratory.

North America was the largest region in the hereditary cancer testing market in 2023. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hereditary cancer testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hereditary cancer testing market includes revenues earned by entities by providing hereditary cancer testing for lung cancer, cervical cancer, prostate cancer, stomach/gastric cancer, melanoma, sarcoma, and uterine cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The hereditary cancer testing market research report is one of a series of new reports from The Business Research Company that provides hereditary cancer testing market statistics, including hereditary cancer testing industry global market size, regional shares, competitors with a hereditary cancer testing market share, detailed hereditary cancer testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary cancer testing industry. This hereditary cancer testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hereditary Cancer Testing Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $4.43 billion
Revenue Forecast In 2033 $6.7 billion
Growth Rate CAGR of 10.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Test Type: Multi Panel Test, Single-site Genetic Test
2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications
3) By End user: Hospital, Clinics, Diagnostic Centers
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Centogene NV; Ambry Genetics Inc.; Myriad Genetics Inc.; NeoGenomics Laboratories Inc.; Quest Diagnostics; PreventionGenetics; Fulgent Genetics Inc.; Invitae Corporation; Medical Diagnostic Laboratories LLC; Natera Inc.; Color Health Inc.; CooperSurgical Inc.; OPKO Health Inc.; Illumina Inc.; Laboratory Corporation of America Holdings; Pathway Genomics Corporation; Strand Life Sciences Private Limited; Progenity Inc.; Myogenes Ltd.; Associated Regional and University Pathologists Inc.; 4baseCare; Biocartis Group NV; F. Hoffmann-La Roche AG; Medgenome Pvt. Ltd.; Abbott Laboratories; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies PLC; PerkinElmer Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Hereditary Cancer Testing Market Characteristics

    3. Hereditary Cancer Testing Market Trends And Strategies

    4. Hereditary Cancer Testing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Hereditary Cancer Testing Market Size and Growth

    5.1. Global Hereditary Cancer Testing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Hereditary Cancer Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Hereditary Cancer Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Hereditary Cancer Testing Market Segmentation

    6.1. Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Multi Panel Test

    Single-site Genetic Test

    6.2. Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Breast Cancer

    Ovarian Cancer

    Colorectal Cancer

    Other Indications

    6.3. Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital

    Clinics

    Diagnostic Centers

    7. Hereditary Cancer Testing Market Regional And Country Analysis

    7.1. Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Hereditary Cancer Testing Market  

    8.1. Asia-Pacific Hereditary Cancer Testing Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Hereditary Cancer Testing Market  

    9.1. China Hereditary Cancer Testing Market Overview  

    9.2. China Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Hereditary Cancer Testing Market  

    10.1. India Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Hereditary Cancer Testing Market  

    11.1. Japan Hereditary Cancer Testing Market Overview  

    11.2. Japan Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Hereditary Cancer Testing Market  

    12.1. Australia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Hereditary Cancer Testing Market  

    13.1. Indonesia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Hereditary Cancer Testing Market  

    14.1. South Korea Hereditary Cancer Testing Market Overview  

    14.2. South Korea Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Hereditary Cancer Testing Market  

    15.1. Western Europe Hereditary Cancer Testing Market Overview

    15.2. Western Europe Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Hereditary Cancer Testing Market  

    16.1. UK Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Hereditary Cancer Testing Market  

    17.1. Germany Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Hereditary Cancer Testing Market  

    18.5. France Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Hereditary Cancer Testing Market  

    19.9. Italy Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Hereditary Cancer Testing Market  

    20.13. Spain Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Hereditary Cancer Testing Market  

    21.1. Eastern Europe Hereditary Cancer Testing Market Overview

    21.2. Eastern Europe Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Hereditary Cancer Testing Market  

    22.1. Russia Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Hereditary Cancer Testing Market  

    23.1. North America Hereditary Cancer Testing Market Overview

    23.2. North America Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Hereditary Cancer Testing Market  

    24.1. USA Hereditary Cancer Testing Market Overview

    24.2. USA Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Hereditary Cancer Testing Market  

    25.1. Canada Hereditary Cancer Testing Market Overview

    25.2. Canada Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Hereditary Cancer Testing Market  

    26.1. South America Hereditary Cancer Testing Market Overview

    26.2. South America Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Hereditary Cancer Testing Market  

    27.1. Brazil Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Hereditary Cancer Testing Market  

    28.1. Middle East Hereditary Cancer Testing Market Overview

    28.2. Middle East Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Hereditary Cancer Testing Market  

    29.1. Africa Hereditary Cancer Testing Market Overview

    29.2. Africa Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Hereditary Cancer Testing Market Competitive Landscape And Company Profiles

    30.1. Hereditary Cancer Testing Market Competitive Landscape

    30.2. Hereditary Cancer Testing Market Company Profiles

    30.2.1. Centogene NV

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Ambry Genetics Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Myriad Genetics Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. NeoGenomics Laboratories Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Quest Diagnostics

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Hereditary Cancer Testing Market Competitive Benchmarking

    32. Global Hereditary Cancer Testing Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Hereditary Cancer Testing Market

    34. Hereditary Cancer Testing Market Future Outlook and Potential Analysis

    34.1 Hereditary Cancer Testing Market In 2028 - Countries Offering Most New Opportunities

    34.2 Hereditary Cancer Testing Market In 2028 - Segments Offering Most New Opportunities

    34.3 Hereditary Cancer Testing Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Centogene NV Financial Performance
  • Table 75: Ambry Genetics Inc. Financial Performance
  • Table 76: Myriad Genetics Inc. Financial Performance
  • Table 77: NeoGenomics Laboratories Inc. Financial Performance
  • Table 78: Quest Diagnostics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Centogene NV Financial Performance
  • Figure 75: Ambry Genetics Inc. Financial Performance
  • Figure 76: Myriad Genetics Inc. Financial Performance
  • Figure 77: NeoGenomics Laboratories Inc. Financial Performance
  • Figure 78: Quest Diagnostics Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the hereditary cancer testing market?

The hereditary cancer testing refers to testing methods for hereditary cancers that can identify specific hereditary cancer diseases and disease-related gene mutations. This testing may decrease the risk of developing particular cancer mutants, allowing for a more comprehensive cancer risk for patients. The primary purpose of this cancer testing is to detect hereditary cancer early and maximize patient health outcomes. This testing procedure assists in identifying cancers for which one has a genetic risk and allows them to receive preventive treatment. For further insights on the hereditary cancer testing market, request a sample here

How will the hereditary cancer testing market drivers and restraints affect the hereditary cancer testing market dynamics? What forces will shape the hereditary cancer testing industry going forward?

The hereditary cancer testing market major growth driver - unraveling hereditary cancer with the rising demand for hereditary cancer testing. For further insights on the hereditary cancer testing market, request a sample here

What is the forecast market size or the forecast market value of the hereditary cancer testing market ?

The hereditary cancer testing market size has grown rapidly in recent years. It will grow from $3.97 billion in 2023 to $4.43 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising incidence of hereditary cancers, genetic counseling programs, government initiatives for cancer prevention, improved insurance coverage, understanding of gene-environment interactions, patient advocacy and support groups. The hereditary cancer testing market size is expected to see rapid growth in the next few years. It will grow to $6.7 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to expansion of targeted therapies, advancements in precision medicine, rise in direct-to-consumer testing, global health initiatives, advancements in bioinformatics. Major trends in the forecast period include advancements in genetic sequencing technologies, telemedicine and remote genetic counseling, precision medicine and personalized treatment, cancer risk assessment models, ethical and legal considerations. For further insights on the hereditary cancer testing market, request a sample here

How is the hereditary cancer testing market segmented?

The hereditary cancer testing market is segmentedThe hereditary cancer testing market covered in this report is segmented –
1) By Test Type: Multi Panel Test, Single-site Genetic Test
2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications
3) By End user: Hospital, Clinics, Diagnostic CentersFor further insights on the hereditary cancer testing market,
request a sample here

Which region has the largest share of the hereditary cancer testing market? What are the other regions covered in the report?

North America was the largest region in the hereditary cancer testing market in 2023. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the hereditary cancer testing market, request a sample here.

Who are the major players in the hereditary cancer testing market?

Major companies operating in the hereditary cancer testing market report are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc, PerkinElmer Inc. For further insights on the hereditary cancer testing market, request a sample here.

What are the key trends in the hereditary cancer testing market?

Major trend in the hereditary cancer testing market - myriad genetics' cutting-edge approach in hereditary cancer testing technology. For further insights on the hereditary cancer testing market, request a sample here.

What are the major opportunities in the hereditary cancer testing market? What are the strategies for the hereditary cancer testing market?

For detailed insights on the major opportunities and strategies in the hereditary cancer testing market, request a sample here.

How does the hereditary cancer testing market relate to the overall economy and other similar markets?

For detailed insights on hereditary cancer testing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the hereditary cancer testing industry?

For detailed insights on the mergers and acquisitions in the hereditary cancer testing industry, request a sample here.

What are the key dynamics influencing the hereditary cancer testing market growth? SWOT analysis of the hereditary cancer testing market.

For detailed insights on the key dynamics influencing the hereditary cancer testing market growth and SWOT analysis of the hereditary cancer testing industry, request a sample here.